Compugen Ltd. is an Israeli biotechnology company that uses predictive discovery platforms to develop innovative drugs targeting cancer and other diseases. With a focus on immunotherapy and antibody therapeutics, Compugen is at the forefront of pioneering research in the field of precision medicine.
Notification